US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Intellia Therapeutics

10.74

+0.01000.09%

Post-market: 10.70-0.0400-0.37%16:57 EDT

Volume:2.81M

Turnover:29.97M

Market Cap:1.11B

PE:-2.06

High:10.90

Open:10.80

Low:10.45

Close:10.73

Loading ...

Overview Company News Filings

Intellia Therapeutics Executive Makes Significant Stock Sale

Eliana Clark, EVP and Chief Technical Officer, Reports Disposal of Intellia Therapeutics Common Shares

Director Jesse Goodman Reports Disposal of Common Shares in Intellia Therapeutics Inc

Wedbush Reaffirms Their Hold Rating on Intellia Therapeutics (NTLA)

Intellia Therapeutics Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Intellia Therapeutics Announces Positive Phase 1 Trial Data

Intellia Therapeutics Announces Promising Phase 3 Trial Results for Lonvo-z, Plans for 2027 U.S. Launch

Intellia Therapeutics Says Potential Hereditary Angioedema Treatment Reduces Attacks

MT Newswires Live

Intellia Therapeutics Announces Positive Three-Year Data From Phase 1 Trial of Lonvoguran Ziclumeran (Lonvo-Z) in Patients With Hereditary Angioedema (Hae) at the European Academy of Allergy and Clinical Immunology Congress

THOMSON REUTERS

Intellia Therapeutics Inc. Conducted Annual Meeting of Stockholders

Bernstein Remains a Buy on Intellia Therapeutics (NTLA)

BEAM Up on FDA's Orphan Drug Status for Gene-Editing Therapy

How Much Upside is Left in Intellia Therapeutics (NTLA)? Wall Street Analysts Think 398.31%

Can CRISPR Build on Casgevy's Success With Its In Vivo Pipeline?

Intellia Therapeutics Is Maintained at Buy by Canaccord Genuity

Intellia Therapeutics price target lowered to $54 from $74 at Canaccord

Positive Outlook on Intellia Therapeutics Despite Mild Adverse Event in Phase 3 Study

Intellia Therapeutics: Positive Outlook and Strong Enrollment Support Buy Rating

Evercore ISI Sticks to Its Buy Rating for Intellia Therapeutics (NTLA)

Intellia's Stock Drops Following Adverse Event in Nex-Z Trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NTLA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NTLA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTLA\",,,,,undefined,":{"symbol":"NTLA","market":"US","secType":"STK","nameCN":"Intellia Therapeutics","latestPrice":10.74,"timestamp":1751562000000,"preClose":10.73,"halted":0,"volume":2811328,"hourTrading":{"tag":"盘后","latestPrice":10.7,"preClose":10.74,"latestTime":"16:57 EDT","volume":28025,"amount":299593.4719,"timestamp":1751576259740},"delay":0,"floatShares":98412738,"shares":103583394,"eps":-5.214891,"marketStatus":"Closed Independence Day","change":0.01,"latestTime":"07-03 13:00:00 EDT","open":10.8,"high":10.895,"low":10.45,"amount":29974367.890688002,"amplitude":0.041473,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.214891,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1751875200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1462507200000,"exchange":"NASDAQ","adjPreClose":10.73,"preHourTrading":{"tag":"盘前","latestPrice":10.86,"preClose":10.73,"latestTime":"09:29 EDT","volume":9872,"amount":107486.19779199999,"timestamp":1751549399999},"postHourTrading":{"tag":"盘后","latestPrice":10.7,"preClose":10.74,"latestTime":"16:57 EDT","volume":28025,"amount":299593.4719,"timestamp":1751576259740},"volumeRatio":1.1579947960042352,"impliedVol":0.8835,"impliedVolPercentile":0.548},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTLA\",,,,,undefined,":{"symbol":"NTLA","floatShares":98412738,"roa":"-30.12%","roe":"-57.92%","lyrEps":-5.250644,"volumeRatio":1.1579947960042352,"shares":103583394,"dividePrice":0,"high":10.895,"amplitude":0.041473,"preClose":10.73,"low":10.45,"week52Low":5.9,"pbRate":"1.43","psRate":"24.41","week52High":28.18,"institutionHeld":0,"latestPrice":10.74,"eps":-5.214891,"divideRate":0,"volume":2811328,"delay":0,"ttmEps":-5.214891,"open":10.8,"prevYearClose":11.66,"prevWeekClose":9.56,"prevMonthClose":9.38,"prevQuarterClose":9.38,"fiveDayClose":9.61,"twentyDayClose":7.67,"sixtyDayClose":6.54},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NTLA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2548033743","title":"Intellia Therapeutics Executive Makes Significant Stock Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2548033743","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548033743?lang=en_us&edition=fundamental","pubTime":"2025-07-04 10:05","pubTimestamp":1751594750,"startTime":"0","endTime":"0","summary":"New insider activity at Intellia Therapeutics ( ($NTLA) ) has taken place on July 3, 2025. VP & CAO Michael P Dube recently sold 2,503 shares of In...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/intellia-therapeutics-executive-makes-significant-stock-sale-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/intellia-therapeutics-executive-makes-significant-stock-sale-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861559042.SGD","BK4535","BK4588","BK4556","LU1861558580.USD","BK4139","BK4585","NTLA"],"gpt_icon":0},{"id":"2548875843","title":"Eliana Clark, EVP and Chief Technical Officer, Reports Disposal of Intellia Therapeutics Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2548875843","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548875843?lang=en_us&edition=fundamental","pubTime":"2025-07-04 04:12","pubTimestamp":1751573554,"startTime":"0","endTime":"0","summary":"Eliana Clark, EVP and Chief Technical Officer of Intellia Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intellia Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 03, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250703:nNDL96wFmM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","LU1861558580.USD","BK4139","LU1861559042.SGD","NTLA","BK4588","BK4556","BK4585"],"gpt_icon":0},{"id":"2548843326","title":"Director Jesse Goodman Reports Disposal of Common Shares in Intellia Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2548843326","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548843326?lang=en_us&edition=fundamental","pubTime":"2025-07-03 05:50","pubTimestamp":1751493050,"startTime":"0","endTime":"0","summary":"Jesse Goodman, a Director at Intellia Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intellia Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 02, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nNDLb4GnBH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4585","BK4556","NTLA","LU1861558580.USD","BK4588","BK4139","LU1861559042.SGD"],"gpt_icon":0},{"id":"2543606073","title":"Wedbush Reaffirms Their Hold Rating on Intellia Therapeutics (NTLA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2543606073","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543606073?lang=en_us&edition=fundamental","pubTime":"2025-06-16 22:45","pubTimestamp":1750085117,"startTime":"0","endTime":"0","summary":"Wedbush analyst maintained a Hold rating on Intellia Therapeutics (NTLA – Research Report) today and set a price target of $7.00. The company’s sha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wedbush-reaffirms-their-hold-rating-on-intellia-therapeutics-ntla-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wedbush-reaffirms-their-hold-rating-on-intellia-therapeutics-ntla-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NTLA"],"gpt_icon":0},{"id":"2543672547","title":"Intellia Therapeutics Price Target Maintained With a $30.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2543672547","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543672547?lang=en_us&edition=fundamental","pubTime":"2025-06-16 20:07","pubTimestamp":1750075620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NTLA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 16, 2025 08:07 ET (12:07 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTLA"],"gpt_icon":0},{"id":"2543674638","title":"Intellia Therapeutics Announces Positive Phase 1 Trial Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2543674638","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543674638?lang=en_us&edition=fundamental","pubTime":"2025-06-16 19:30","pubTimestamp":1750073457,"startTime":"0","endTime":"0","summary":"Intellia Therapeutics ( ($NTLA) ) has issued an update. On June 15, 2025, Intellia Therapeutics announced positive three-year data from the Phase 1...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/intellia-therapeutics-announces-positive-phase-1-trial-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/intellia-therapeutics-announces-positive-phase-1-trial-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","LU1861559042.SGD","BK4585","LU1861558580.USD","NTLA","BK4588","BK4556","BK4139"],"gpt_icon":0},{"id":"2543867970","title":"Intellia Therapeutics Announces Promising Phase 3 Trial Results for Lonvo-z, Plans for 2027 U.S. Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2543867970","media":"Reuters","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543867970?lang=en_us&edition=fundamental","pubTime":"2025-06-16 19:01","pubTimestamp":1750071692,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass. June 15, 2025  - Intellia Therapeutics, Inc. , a clinical-stage gene editing company, has announced three-year follow-up data from the Phase 1 portion of its ongoing Phase 1/2 study in patients with hereditary angioedema  using a single dose of lonvoguran ziclumeran . The results were presented at the European Academy of Allergy and Clinical Immunology  Congress 2025 in Glasgow, United Kingdom. The Phase 3 HAELO trial, a global, randomized, double-blind, placebo-controlled study, has completed screening ahead of schedule, with over half of the participants screened in the United States. Intellia plans to report the outcomes of the Phase 3 study in the first half of 2026 and aims to submit a biologics license application  in 2026 to support a U.S. launch in 2027.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nNDL8Fnvr1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","NTLA","LU1861558580.USD","BK4585","BK4535","LU1861559042.SGD","BK4139","BK4556"],"gpt_icon":0},{"id":"2543362993","title":"Intellia Therapeutics Says Potential Hereditary Angioedema Treatment Reduces Attacks","url":"https://stock-news.laohu8.com/highlight/detail?id=2543362993","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543362993?lang=en_us&edition=fundamental","pubTime":"2025-06-16 16:27","pubTimestamp":1750062447,"startTime":"0","endTime":"0","summary":"Intellia Therapeutics  said Sunday that 10 patients with hereditary angioedema patients in a phase 1/2 study were attack-free and treatment-free for a median of nearly two years after a single dose of its Crispr-based potential therapy lonvoguran ziclumeran.The genetic disease recurrent swelling and possible abdominal pain.With up to three years of follow-up, patients in the study experienced a mean reduction of monthly attacks of 98% after the single dose, the company said.A phase 3, randomized, double-blind, placebo-controlled trial is ongoing, the company said.Intellia also said it expects to submit a biologics license application in 2026 to support its plans for a US launch in 2027.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","NTLA","BK4588","BK4556","LU1861559042.SGD","BK4535","LU1861558580.USD","BK4585"],"gpt_icon":0},{"id":"2543167613","title":"Intellia Therapeutics Announces Positive Three-Year Data From Phase 1 Trial of Lonvoguran Ziclumeran (Lonvo-Z) in Patients With Hereditary Angioedema (Hae) at the European Academy of Allergy and Clinical Immunology Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2543167613","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543167613?lang=en_us&edition=fundamental","pubTime":"2025-06-15 22:45","pubTimestamp":1749998700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250615:nTUAY1SGY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1861559042.SGD","LU1861558580.USD","BK4585","NTLA","BK4139","BK4556","BK4535","BK4588"],"gpt_icon":0},{"id":"2543473485","title":"Intellia Therapeutics Inc. Conducted Annual Meeting of Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2543473485","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543473485?lang=en_us&edition=fundamental","pubTime":"2025-06-13 04:32","pubTimestamp":1749760352,"startTime":"0","endTime":"0","summary":"Intellia Therapeutics Inc. held its annual meeting on June 11, 2025. Stockholders approved the 2025 Equity Incentive Plan. William Chase, Georgia Keresty, Ph.D., M.P.H., and John M. Leonard, M.D., were elected as class III directors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intellia Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 12, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nNDL1q1VtC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4139","LU1861558580.USD","LU1861559042.SGD","BK4556","BK4585","NTLA","BK4588"],"gpt_icon":0},{"id":"2541077197","title":"Bernstein Remains a Buy on Intellia Therapeutics (NTLA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2541077197","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541077197?lang=en_us&edition=fundamental","pubTime":"2025-06-06 00:55","pubTimestamp":1749142531,"startTime":"0","endTime":"0","summary":"Bernstein analyst William Pickering maintained a Buy rating on Intellia Therapeutics (NTLA – Research Report) today and set a price target of $14.0...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bernstein-remains-a-buy-on-intellia-therapeutics-ntla-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bernstein-remains-a-buy-on-intellia-therapeutics-ntla-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861559042.SGD","LU1861558580.USD","BK4535","BK4139","BK4556","BK4588","NTLA","BK4585"],"gpt_icon":0},{"id":"2541737093","title":"BEAM Up on FDA's Orphan Drug Status for Gene-Editing Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2541737093","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541737093?lang=en_us&edition=fundamental","pubTime":"2025-06-04 22:58","pubTimestamp":1749049080,"startTime":"0","endTime":"0","summary":"Beam TherapeuticsBEAM announced that the FDA has granted an orphan drug designation to its investigational genome-editing candidate, BEAM-101, for the treatment of sickle cell disease , an inherited blood disorder.The FDA grants orphan drug designation to support the development of medicines for rare disorders that affect fewer than 200,000 people in the United States. The designation makes the sponsor eligible to receive seven years of market exclusivity following a potential approval, along with the exemption of FDA application fees and tax credits for qualified clinical studies.Shares of Beam Therapeutics were up 4.3% yesterday following the announcement of the news.However, the stock has plunged 32% so far this year compared with the industry’s decline of 2.9%.In December 2024, the company announced new safety and efficacy data from the BEACON study evaluating BEAM-101 in SCD patients with severe vaso-occlusive crises.The data showed that treatment with BEAM-101 led to a robust and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/beam-fdas-orphan-drug-status-145800778.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0234570918.USD","IE0009355771.USD","LU1035775433.USD","CRSP","LU1430594728.SGD","LU0061475181.USD","LU0320765992.SGD","IE00BZ9MQY76.HKD","IE00B894F039.SGD","LU0889565916.HKD","BK4567","BK4585","LU0079474960.USD","SCD","IE00BJJMRZ35.SGD","BK4611","IE00B2B36J28.USD","LU1093756168.USD","IE00B19Z3B42.SGD","LU1778281490.HKD","NTLA","LU0109394709.USD","LU2456880835.USD","VRTX","LU0058720904.USD","SG9999013999.USD","LU1093756325.SGD","LU2362541513.USD","LU2362541273.HKD","LU1861558580.USD","BK4505","BK4139","LU0417517546.SGD","SG9999001176.SGD","SG9999001176.USD","IE00B19Z3581.USD","SGXZ57979304.SGD","IE00BFTCPJ56.SGD","IE00B19Z9P08.USD","LU2236285917.USD","LU2362540622.SGD","BEAM","LU1585245621.USD","LU2324357040.USD","BK4533","LU2237438978.USD","BK4588","IE0002270589.USD","BK4535","LU2462157665.USD"],"gpt_icon":0},{"id":"2541509375","title":"How Much Upside is Left in Intellia Therapeutics (NTLA)? Wall Street Analysts Think 398.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541509375","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541509375?lang=en_us&edition=fundamental","pubTime":"2025-06-04 21:55","pubTimestamp":1749045309,"startTime":"0","endTime":"0","summary":"Shares of Intellia Therapeutics, Inc.  have gained 6.1% over the past four weeks to close the last trading session at $7.69, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $38.32 indicates a potential upside of 398.3%.However, an impressive consensus price target is not the only factor that indicates a potential upside in NTLA. This view is strengthened by the agreement among analysts that the company will report better earnings than what they estimated earlier. Though a positive trend in earnings estimate revisions doesn't give any idea as to how much the stock could surge, it has proven effective in predicting an upside.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/much-upside-left-intellia-therapeutics-135509183.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","LU1861559042.SGD","BK4556","BK4585","LU1861558580.USD","NTLA","BK4139","BK4535"],"gpt_icon":0},{"id":"2541093732","title":"Can CRISPR Build on Casgevy's Success With Its In Vivo Pipeline?","url":"https://stock-news.laohu8.com/highlight/detail?id=2541093732","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541093732?lang=en_us&edition=fundamental","pubTime":"2025-06-04 20:55","pubTimestamp":1749041700,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics is currently evaluating two in vivo candidates, namely CTX310 and CTX320, in separate early-stage studies, targeting ANGPTL3 and lipoprotein [Lp], respectively — both associated with atherosclerotic heart disease.Last month, CRSP reported initial top-line data from the first 10 patients acrossthe first four cohorts of the phase I study on CTX310. A single dose demonstrated dose-dependent decreases in low-density lipoprotein  and triglyceride  levels, with peak reduction of up to 82% in TG and up to 81% in LDL.These results have raised excitement around CTX320, a readout from which is expected later in the second quarter of 2025. CRISPR Therapeutics also intends to advance two additional in vivo programs into the clinic by year-end, further expanding its footprint in this emerging modality.The company is currently lagging behind Intellia TherapeuticsNTLA, which is one of the few companies with multiple clinical-stage in vivo gene editing programs. Intellia is advanci","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/crispr-build-casgevys-success-vivo-125500765.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BGSX","CRSP","BK4153","BK4585","HAE","TG","LU1169590202.USD","BK4611","LU1169589451.USD","LU1861558580.USD","BK4090","BK4556","LU0106261612.USD","LDL","IE00BLDYK493.USD","LU0205194284.USD","NTLA","BEAM","IE00B64QTZ34.USD","BK4588","BK4505","LU0012050646.USD","BK4198","LU1861559042.SGD","BK4139","BK4535","LU0205193047.USD"],"gpt_icon":0},{"id":"2540776734","title":"Intellia Therapeutics Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2540776734","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540776734?lang=en_us&edition=fundamental","pubTime":"2025-06-03 19:44","pubTimestamp":1748951040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NTLA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 03, 2025 07:44 ET (11:44 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTLA"],"gpt_icon":0},{"id":"2540775627","title":"Intellia Therapeutics price target lowered to $54 from $74 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2540775627","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540775627?lang=en_us&edition=fundamental","pubTime":"2025-06-03 18:50","pubTimestamp":1748947841,"startTime":"0","endTime":"0","summary":"Canaccord lowered the firm’s price target on Intellia Therapeutics (NTLA) to $54 from $74 and keeps a Buy rating on the shares. The target reductio...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/intellia-therapeutics-price-target-lowered-to-54-from-74-at-canaccord-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/intellia-therapeutics-price-target-lowered-to-54-from-74-at-canaccord-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NTLA"],"gpt_icon":0},{"id":"2539223844","title":"Positive Outlook on Intellia Therapeutics Despite Mild Adverse Event in Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2539223844","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539223844?lang=en_us&edition=fundamental","pubTime":"2025-05-30 17:57","pubTimestamp":1748599030,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Yanan Zhu from Wells Fargo maintained a Buy rating on Intellia Therapeutics (NTLA – Research Report), with a price ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/positive-outlook-on-intellia-therapeutics-despite-mild-adverse-event-in-phase-3-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/positive-outlook-on-intellia-therapeutics-despite-mild-adverse-event-in-phase-3-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1267930227.SGD","LU0154236417.USD","LU1668664300.SGD","LU2361045086.USD","LU1201861249.SGD","BK4556","LU0211327993.USD","LU1069347547.HKD","LU0251131958.USD","LU0106831901.USD","LU0314106906.USD","LU0130102774.USD","LU0980610538.SGD","BK4559","BK4501","LU0072461881.USD","IE00B19Z3581.USD","LU0289960550.SGD","IE0002270589.USD","BK4585","LU0310799852.SGD","LU0320765489.SGD","LU1035773651.USD","LU0128525929.USD","LU2461242641.AUD","LU0251142724.SGD","NTLA","LU0708994859.HKD","LU1861559042.SGD","BK4207","LU1861558580.USD","LU1267930490.SGD","LU0149725797.USD","LU0640476718.USD","LU0971096721.USD","LU0267386448.USD","LU0477156953.USD","LU1267930573.SGD","LU1280957306.USD","LU0029864427.USD","LU0648001328.SGD","LU2361044949.HKD","LU1074936037.SGD","LU0310800379.SGD","LU0310800965.SGD","LU1814569148.SGD","BK4535","LU0128525689.USD","LU0070302665.USD","LU0683600562.USD"],"gpt_icon":0},{"id":"2539249389","title":"Intellia Therapeutics: Positive Outlook and Strong Enrollment Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2539249389","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539249389?lang=en_us&edition=fundamental","pubTime":"2025-05-30 16:06","pubTimestamp":1748592395,"startTime":"0","endTime":"0","summary":"Leerink Partners analyst Mani Foroohar has maintained their bullish stance on NTLA stock, giving a Buy rating today. Mani Foroohar has given his Bu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/intellia-therapeutics-positive-outlook-and-strong-enrollment-support-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/intellia-therapeutics-positive-outlook-and-strong-enrollment-support-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NTLA"],"gpt_icon":0},{"id":"2539524654","title":"Evercore ISI Sticks to Its Buy Rating for Intellia Therapeutics (NTLA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2539524654","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539524654?lang=en_us&edition=fundamental","pubTime":"2025-05-30 15:57","pubTimestamp":1748591861,"startTime":"0","endTime":"0","summary":"Evercore ISI analyst Liisa Bayko maintained a Buy rating on Intellia Therapeutics (NTLA – Research Report) yesterday and set a price target of $48....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/evercore-isi-sticks-to-its-buy-rating-for-intellia-therapeutics-ntla-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/evercore-isi-sticks-to-its-buy-rating-for-intellia-therapeutics-ntla-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NTLA"],"gpt_icon":0},{"id":"2539262836","title":"Intellia's Stock Drops Following Adverse Event in Nex-Z Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2539262836","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539262836?lang=en_us&edition=fundamental","pubTime":"2025-05-29 23:55","pubTimestamp":1748534100,"startTime":"0","endTime":"0","summary":"Shares of Intellia Therapeutics fell after the company reported a grade 4 adverse event in a study of nex-z, its treatment for hereditary ATTR amyloidosis with polyneuropathy.The stock was down 24% to $7.32 on Thursday. Shares have declined 66% in the past 12 months.An asymptomatic patient in the Phase 3 study who was dosed with the treatment had grade 4 liver transaminase elevations, based on laboratory tests, according to a filing with the Securities and Exchange Commission on Wednesday.The effects appear to be resolving without hospitalization or medical intervention, the company said.Analysts at Oppenheimer said in a note they are not overly concerned by the safety findings. There are no signs of liver injury and similar transient liver enzyme elevations previously occurred around a similar timeline in the company's Phase 1 trial, they said.In the over 200 patients dosed with nex-z in the study so far, adverse events are similar to those reported in the drug's Phase 1 study, the co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4556","BK4535","LU1861558580.USD","LU1861559042.SGD","NTLA","BK4588","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":189,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NTLA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-08","symbol":"NTLA","fiscalQuarterEnding":"2025/03","expectedEps":-1.26,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-1.1},{"market":"US","date":"2025-02-27","symbol":"NTLA","fiscalQuarterEnding":"2024/12","expectedEps":-1.32,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":-1.24},{"market":"US","date":"2024-11-07","symbol":"NTLA","fiscalQuarterEnding":"2024/09","expectedEps":-1.37,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-1.34},{"market":"US","date":"2024-08-08","symbol":"NTLA","fiscalQuarterEnding":"2024/06","expectedEps":-1.21,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-1.31},{"market":"US","date":"2024-05-09","symbol":"NTLA","fiscalQuarterEnding":"2024/03","expectedEps":-1.35,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-1.06}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NTLA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NTLA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.4643,"hold":0.2143,"sell":0.0357,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4643,"analysts":28,"updateTime":1745294400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NTLA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NTLA","date":"2025-07-03","current":-2.115338,"percent":0.91102,"low":-83.48813,"twenty":-31.205508,"median":-8.875733,"eighty":-4.577887,"high":-1.252531,"avg":-16.345704,"sd":17.208663,"marketCap":1112485651},"quantilePoints":[{"date":"2020-07-10","current":-12.554089,"twenty":-32.670843,"median":-13.34277,"eighty":-7.720027,"marketCap":1373404824},{"date":"2020-07-17","current":-11.388842,"twenty":-32.663965,"median":-13.168164,"eighty":-7.741162,"marketCap":1245927938},{"date":"2020-07-24","current":-10.097052,"twenty":-32.65231,"median":-13.149163,"eighty":-7.760646,"marketCap":1104607408},{"date":"2020-07-31","current":-9.390522,"twenty":-32.632914,"median":-13.078845,"eighty":-7.769143,"marketCap":1027313730},{"date":"2020-08-07","current":-10.03218,"twenty":-32.618081,"median":-12.941295,"eighty":-7.782678,"marketCap":1164826355},{"date":"2020-08-14","current":-10.062534,"twenty":-32.586797,"median":-12.85327,"eighty":-7.794251,"marketCap":1168350792},{"date":"2020-08-21","current":-10.259839,"twenty":-32.541974,"median":-12.820737,"eighty":-7.800866,"marketCap":1191259631},{"date":"2020-08-28","current":-10.796103,"twenty":-32.541974,"median":-12.716185,"eighty":-7.808314,"marketCap":1253524681},{"date":"2020-09-04","current":-9.167075,"twenty":-32.532743,"median":-12.671282,"eighty":-7.823209,"marketCap":1064379907},{"date":"2020-09-11","current":-9.743811,"twenty":-32.49507,"median":-12.588542,"eighty":-7.835976,"marketCap":1131344206},{"date":"2020-09-18","current":-11.893926,"twenty":-32.393136,"median":-12.276991,"eighty":-7.83662,"marketCap":1380991811},{"date":"2020-09-25","current":-10.765748,"twenty":-32.366613,"median":-12.145985,"eighty":-7.840543,"marketCap":1250000244},{"date":"2020-10-02","current":-9.526271,"twenty":-32.361603,"median":-12.03405,"eighty":-7.846211,"marketCap":1106085742},{"date":"2020-10-09","current":-13.310471,"twenty":-32.33698,"median":-12.020986,"eighty":-7.848131,"marketCap":1545465528},{"date":"2020-10-16","current":-13.20929,"twenty":-32.286619,"median":-12.058464,"eighty":-7.851509,"marketCap":1533717405},{"date":"2020-10-23","current":-12.587021,"twenty":-32.142446,"median":-12.114597,"eighty":-7.852999,"marketCap":1461466451},{"date":"2020-10-30","current":-12.111467,"twenty":-32.07036,"median":-12.159065,"eighty":-7.857431,"marketCap":1406250275},{"date":"2020-11-06","current":-13.778887,"twenty":-32.036609,"median":-12.272645,"eighty":-7.858977,"marketCap":1657806770},{"date":"2020-11-13","current":-16.31762,"twenty":-32.026542,"median":-12.318889,"eighty":-7.865576,"marketCap":1963254419},{"date":"2020-11-20","current":-15.880584,"twenty":-31.959002,"median":-12.422601,"eighty":-7.878534,"marketCap":1910672522},{"date":"2020-11-27","current":-19.337582,"twenty":-31.740324,"median":-12.526312,"eighty":-7.878534,"marketCap":2326601234},{"date":"2020-12-04","current":-23.321982,"twenty":-31.740324,"median":-12.565131,"eighty":-7.87874,"marketCap":2805984298},{"date":"2020-12-11","current":-28.594125,"twenty":-31.724101,"median":-12.617195,"eighty":-7.881296,"marketCap":3440302111},{"date":"2020-12-18","current":-29.748412,"twenty":-31.665169,"median":-12.672477,"eighty":-7.883854,"marketCap":3579180247},{"date":"2020-12-24","current":-33.361602,"twenty":-31.794994,"median":-12.716185,"eighty":-7.889258,"marketCap":4013901111},{"date":"2020-12-31","current":-29.206166,"twenty":-31.849663,"median":-12.784326,"eighty":-7.893682,"marketCap":3513939820},{"date":"2021-01-08","current":-42.069764,"twenty":-32.054341,"median":-12.833817,"eighty":-7.89818,"marketCap":5061623609},{"date":"2021-01-15","current":-43.964943,"twenty":-32.351582,"median":-12.861927,"eighty":-7.900785,"marketCap":5289642130},{"date":"2021-01-22","current":-39.922251,"twenty":-32.471244,"median":-12.927782,"eighty":-7.90468,"marketCap":4803245681},{"date":"2021-01-29","current":-33.619303,"twenty":-32.541974,"median":-13.010213,"eighty":-7.912798,"marketCap":4044906462},{"date":"2021-02-05","current":-37.15733,"twenty":-32.65231,"median":-13.142644,"eighty":-7.919038,"marketCap":4470584099},{"date":"2021-02-12","current":-36.658033,"twenty":-32.687277,"median":-13.156842,"eighty":-7.921888,"marketCap":4410511230},{"date":"2021-02-19","current":-38.853864,"twenty":-32.764668,"median":-13.188727,"eighty":-7.925309,"marketCap":4674702662},{"date":"2021-02-26","current":-30.505135,"twenty":-32.797883,"median":-13.272941,"eighty":-7.935242,"marketCap":4094734818},{"date":"2021-03-05","current":-26.140772,"twenty":-32.787412,"median":-13.418778,"eighty":-7.940222,"marketCap":3508901934},{"date":"2021-03-12","current":-33.058162,"twenty":-32.797883,"median":-13.53961,"eighty":-7.945771,"marketCap":4437430124},{"date":"2021-03-19","current":-33.148981,"twenty":-32.841261,"median":-13.665167,"eighty":-7.954441,"marketCap":4449620866},{"date":"2021-03-26","current":-32.659567,"twenty":-32.855962,"median":-13.745553,"eighty":-7.959394,"marketCap":4383926311},{"date":"2021-04-01","current":-40.394329,"twenty":-32.901751,"median":-13.768715,"eighty":-7.96365,"marketCap":5422171180},{"date":"2021-04-09","current":-35.641461,"twenty":-33.042877,"median":-13.810384,"eighty":-7.998848,"marketCap":4784189010},{"date":"2021-04-16","current":-35.545597,"twenty":-33.079567,"median":-13.856574,"eighty":-8.000888,"marketCap":4771321005},{"date":"2021-04-23","current":-39.501274,"twenty":-33.199711,"median":-13.890006,"eighty":-8.001585,"marketCap":5302295550},{"date":"2021-04-30","current":-38.959511,"twenty":-33.279806,"median":-13.963259,"eighty":-8.004494,"marketCap":5229574088},{"date":"2021-05-07","current":-31.061863,"twenty":-33.318572,"median":-14.015815,"eighty":-8.011528,"marketCap":4616724660},{"date":"2021-05-14","current":-30.740881,"twenty":-33.28521,"median":-14.044842,"eighty":-8.025907,"marketCap":4569017142},{"date":"2021-05-21","current":-29.10846,"twenty":-33.279806,"median":-14.07567,"eighty":-8.035266,"marketCap":4326390337},{"date":"2021-05-28","current":-34.363389,"twenty":-33.279806,"median":-14.107891,"eighty":-8.063791,"marketCap":5107430559},{"date":"2021-06-04","current":-33.125317,"twenty":-33.291882,"median":-14.138939,"eighty":-8.064468,"marketCap":4923415847},{"date":"2021-06-11","current":-39.109334,"twenty":-33.360242,"median":-14.265743,"eighty":-8.073914,"marketCap":5812820288},{"date":"2021-06-18","current":-34.812764,"twenty":-33.549046,"median":-14.305265,"eighty":-8.096587,"marketCap":5174221084},{"date":"2021-06-25","current":-40.732584,"twenty":-33.686755,"median":-14.399538,"eighty":-8.101905,"marketCap":6054084021},{"date":"2021-07-02","current":-80.309891,"twenty":-33.79464,"median":-14.435997,"eighty":-8.106062,"marketCap":11936459045},{"date":"2021-07-09","current":-75.055973,"twenty":-33.811125,"median":-14.456843,"eighty":-8.107861,"marketCap":11155569201},{"date":"2021-07-16","current":-66.348499,"twenty":-33.900549,"median":-14.49131,"eighty":-8.120591,"marketCap":9861377349},{"date":"2021-07-23","current":-67.555281,"twenty":-33.986237,"median":-14.524593,"eighty":-8.129642,"marketCap":10040741403},{"date":"2021-07-30","current":-69.586207,"twenty":-34.028642,"median":-14.549022,"eighty":-8.130247,"marketCap":10342597981},{"date":"2021-08-06","current":-66.444652,"twenty":-34.074766,"median":-14.589121,"eighty":-8.139081,"marketCap":12295117666},{"date":"2021-08-13","current":-61.710803,"twenty":-34.124222,"median":-14.62368,"eighty":-8.14497,"marketCap":11419152077},{"date":"2021-08-20","current":-59.300194,"twenty":-34.25582,"median":-14.68094,"eighty":-8.159981,"marketCap":10973085708},{"date":"2021-08-27","current":-63.541595,"twenty":-34.351809,"median":-14.738299,"eighty":-8.17737,"marketCap":11757927360},{"date":"2021-09-03","current":-70.20552,"twenty":-34.403028,"median":-14.842498,"eighty":-8.18357,"marketCap":12991039991},{"date":"2021-09-10","current":-63.807675,"twenty":-34.461866,"median":-14.904143,"eighty":-8.18596,"marketCap":11807163680},{"date":"2021-09-17","current":-62.465359,"twenty":-34.510259,"median":-14.929336,"eighty":-8.191347,"marketCap":11558777465},{"date":"2021-09-24","current":-59.228709,"twenty":-34.581042,"median":-14.998845,"eighty":-8.199381,"marketCap":10959858040},{"date":"2021-10-01","current":-53.239914,"twenty":-34.68805,"median":-15.083583,"eighty":-8.206093,"marketCap":9851673386},{"date":"2021-10-08","current":-47.938162,"twenty":-34.7581,"median":-15.118835,"eighty":-8.214255,"marketCap":8870621322},{"date":"2021-10-15","current":-51.822142,"twenty":-34.897583,"median":-15.209402,"eighty":-8.223257,"marketCap":9589324632},{"date":"2021-10-22","current":-52.235162,"twenty":-35.098842,"median":-15.26573,"eighty":-8.225648,"marketCap":9665751160},{"date":"2021-10-29","current":-52.811008,"twenty":-35.312764,"median":-15.347652,"eighty":-8.229704,"marketCap":9772307377},{"date":"2021-11-05","current":-44.057131,"twenty":-35.530149,"median":-15.384375,"eighty":-8.230323,"marketCap":10082342208},{"date":"2021-11-12","current":-43.000254,"twenty":-35.530149,"median":-15.384375,"eighty":-8.230323,"marketCap":9840479113},{"date":"2021-11-19","current":-42.105974,"twenty":-35.530149,"median":-15.384375,"eighty":-8.230323,"marketCap":9635825724},{"date":"2021-11-26","current":-36.78907,"twenty":-35.530149,"median":-15.384375,"eighty":-8.230323,"marketCap":8419068305},{"date":"2021-12-03","current":-32.854236,"twenty":-35.411398,"median":-15.384375,"eighty":-8.230323,"marketCap":7518593396},{"date":"2021-12-10","current":-37.07524,"twenty":-35.349639,"median":-15.384375,"eighty":-8.230323,"marketCap":8484557390},{"date":"2021-12-17","current":-41.709238,"twenty":-35.349639,"median":-15.384375,"eighty":-8.230323,"marketCap":9545034039},{"date":"2021-12-23","current":-41.237709,"twenty":-35.349639,"median":-15.384375,"eighty":-8.230323,"marketCap":9437125889},{"date":"2021-12-31","current":-38.450806,"twenty":-35.530149,"median":-15.384375,"eighty":-8.230323,"marketCap":8799351511},{"date":"2022-01-07","current":-34.385895,"twenty":-35.552506,"median":-15.410495,"eighty":-8.230942,"marketCap":7869108836},{"date":"2022-01-14","current":-29.712873,"twenty":-35.525,"median":-15.410495,"eighty":-8.230942,"marketCap":6799701857},{"date":"2022-01-21","current":-26.509723,"twenty":-35.525,"median":-15.410495,"eighty":-8.230942,"marketCap":6066670629},{"date":"2022-01-28","current":-27.973091,"twenty":-35.525,"median":-15.410495,"eighty":-8.230942,"marketCap":6401557992},{"date":"2022-02-04","current":-31.205508,"twenty":-35.525,"median":-15.410495,"eighty":-8.230942,"marketCap":7141286967},{"date":"2022-02-11","current":-29.729133,"twenty":-35.525,"median":-15.410495,"eighty":-8.230942,"marketCap":6803422827},{"date":"2022-02-18","current":-28.135688,"twenty":-35.525,"median":-15.410495,"eighty":-8.230942,"marketCap":6438767699},{"date":"2022-02-25","current":-26.859462,"twenty":-35.525,"median":-15.410495,"eighty":-8.230942,"marketCap":7195435065},{"date":"2022-03-04","current":-18.129301,"twenty":-35.348693,"median":-15.410495,"eighty":-8.230942,"marketCap":4856694652},{"date":"2022-03-11","current":-17.084023,"twenty":-35.329926,"median":-15.410495,"eighty":-8.230942,"marketCap":4576673050},{"date":"2022-03-18","current":-20.161321,"twenty":-35.148611,"median":-15.410495,"eighty":-8.230942,"marketCap":5401056644},{"date":"2022-03-25","current":-19.693037,"twenty":-35.106305,"median":-15.410495,"eighty":-8.230942,"marketCap":5275606967},{"date":"2022-04-01","current":-21.220536,"twenty":-35.082959,"median":-15.410495,"eighty":-8.230942,"marketCap":5684811867},{"date":"2022-04-08","current":-17.56067,"twenty":-34.829829,"median":-15.410495,"eighty":-8.230942,"marketCap":4704362901},{"date":"2022-04-14","current":-16.704935,"twenty":-34.77825,"median":-15.410495,"eighty":-8.230942,"marketCap":4475118550},{"date":"2022-04-22","current":-14.121008,"twenty":-34.616593,"median":-15.284412,"eighty":-8.230942,"marketCap":3782905151},{"date":"2022-04-29","current":-13.666661,"twenty":-34.451464,"median":-15.186936,"eighty":-8.230942,"marketCap":3661189095},{"date":"2022-05-06","current":-9.790477,"twenty":-34.412825,"median":-15.083583,"eighty":-8.230942,"marketCap":3608368595},{"date":"2022-05-13","current":-10.002464,"twenty":-34.412825,"median":-14.939618,"eighty":-8.227527,"marketCap":3686498082},{"date":"2022-05-20","current":-9.825466,"twenty":-34.412825,"median":-14.86595,"eighty":-8.227527,"marketCap":3621263753},{"date":"2022-05-27","current":-10.033336,"twenty":-34.412825,"median":-14.69367,"eighty":-8.227527,"marketCap":3697876162},{"date":"2022-06-03","current":-9.325342,"twenty":-34.412825,"median":-14.608524,"eighty":-8.227527,"marketCap":3436938849},{"date":"2022-06-10","current":-8.73672,"twenty":-34.412825,"median":-14.559919,"eighty":-8.227527,"marketCap":3219996781},{"date":"2022-06-17","current":-8.8458,"twenty":-34.412825,"median":-14.496638,"eighty":-8.222358,"marketCap":3260199332},{"date":"2022-06-24","current":-10.99242,"twenty":-34.4198,"median":-14.45216,"eighty":-8.221802,"marketCap":4051355196},{"date":"2022-07-01","current":-11.115907,"twenty":-34.4198,"median":-14.326554,"eighty":-8.221802,"marketCap":4096867518},{"date":"2022-07-08","current":-13.046424,"twenty":-34.4198,"median":-14.24317,"eighty":-8.221802,"marketCap":4808376819},{"date":"2022-07-15","current":-13.023784,"twenty":-34.393877,"median":-14.107891,"eighty":-8.221802,"marketCap":4800032893},{"date":"2022-07-22","current":-13.408653,"twenty":-34.393877,"median":-14.060765,"eighty":-8.221802,"marketCap":4941879630},{"date":"2022-07-29","current":-13.328386,"twenty":-34.372391,"median":-14.034076,"eighty":-8.221802,"marketCap":4912296621},{"date":"2022-08-05","current":-12.019714,"twenty":-34.372391,"median":-13.963259,"eighty":-8.221802,"marketCap":4813066162},{"date":"2022-08-12","current":-12.85874,"twenty":-34.372391,"median":-13.887181,"eighty":-8.221802,"marketCap":5149038248},{"date":"2022-08-19","current":-10.687143,"twenty":-34.372391,"median":-13.778887,"eighty":-8.221802,"marketCap":4279463439},{"date":"2022-08-26","current":-11.152214,"twenty":-34.372391,"median":-13.745553,"eighty":-8.221802,"marketCap":4465692310},{"date":"2022-09-02","current":-10.632094,"twenty":-34.305075,"median":-13.570879,"eighty":-8.221802,"marketCap":4257420021},{"date":"2022-09-09","current":-12.232318,"twenty":-34.132479,"median":-13.449815,"eighty":-8.221802,"marketCap":4898199360},{"date":"2022-09-16","current":-12.473396,"twenty":-34.01144,"median":-13.408653,"eighty":-8.221802,"marketCap":4994734326},{"date":"2022-09-23","current":-10.23536,"twenty":-33.846934,"median":-13.20929,"eighty":-8.221802,"marketCap":4098555393},{"date":"2022-09-30","current":-10.622603,"twenty":-33.642926,"median":-13.153704,"eighty":-8.221802,"marketCap":4253619432},{"date":"2022-10-07","current":-10.633992,"twenty":-33.255867,"median":-13.046424,"eighty":-8.221802,"marketCap":4258180139},{"date":"2022-10-14","current":-9.941131,"twenty":-33.075764,"median":-13.003203,"eighty":-8.221802,"marketCap":3980737128},{"date":"2022-10-21","current":-9.533008,"twenty":-32.898327,"median":-12.927782,"eighty":-8.221802,"marketCap":3817311792},{"date":"2022-10-28","current":-10.256241,"twenty":-32.759532,"median":-12.85327,"eighty":-8.221802,"marketCap":4106916689},{"date":"2022-11-04","current":-9.067918,"twenty":-32.42156,"median":-12.772608,"eighty":-8.221802,"marketCap":4008164946},{"date":"2022-11-11","current":-9.781745,"twenty":-32.343735,"median":-12.63095,"eighty":-8.221802,"marketCap":4323687943},{"date":"2022-11-18","current":-8.683413,"twenty":-32.145354,"median":-12.554089,"eighty":-8.221802,"marketCap":3838207422},{"date":"2022-11-25","current":-8.843623,"twenty":-31.734272,"median":-12.453685,"eighty":-8.221802,"marketCap":3909023057},{"date":"2022-12-02","current":-8.893352,"twenty":-31.200993,"median":-12.394776,"eighty":-8.221802,"marketCap":3931003978},{"date":"2022-12-09","current":-7.315997,"twenty":-31.036834,"median":-12.303712,"eighty":-8.186729,"marketCap":3233787748},{"date":"2022-12-16","current":-7.10774,"twenty":-31.036834,"median":-12.181065,"eighty":-8.139081,"marketCap":3141734749},{"date":"2022-12-23","current":-6.745218,"twenty":-31.036834,"median":-12.096289,"eighty":-8.105037,"marketCap":2981494344},{"date":"2022-12-30","current":-6.727863,"twenty":-30.780806,"median":-12.048188,"eighty":-8.071595,"marketCap":2973823261},{"date":"2023-01-06","current":-7.34685,"twenty":-30.780806,"median":-12.011451,"eighty":-8.022919,"marketCap":3247425229},{"date":"2023-01-13","current":-7.258148,"twenty":-30.780806,"median":-11.883807,"eighty":-8.000072,"marketCap":3208217471},{"date":"2023-01-20","current":-6.527319,"twenty":-30.780806,"median":-11.841279,"eighty":-7.94962,"marketCap":2885179633},{"date":"2023-01-27","current":-8.027542,"twenty":-30.780806,"median":-11.720779,"eighty":-7.92253,"marketCap":3548302160},{"date":"2023-02-03","current":-8.336071,"twenty":-30.780806,"median":-11.615966,"eighty":-7.921459,"marketCap":3684676973},{"date":"2023-02-10","current":-7.707443,"twenty":-30.780806,"median":-11.564134,"eighty":-7.919723,"marketCap":3406813292},{"date":"2023-02-17","current":-7.786504,"twenty":-30.780806,"median":-11.435053,"eighty":-7.900785,"marketCap":3441759338},{"date":"2023-02-24","current":-7.005262,"twenty":-30.780806,"median":-11.383801,"eighty":-7.882831,"marketCap":3321797017},{"date":"2023-03-03","current":-8.054009,"twenty":-30.780806,"median":-11.305972,"eighty":-7.878534,"marketCap":3819098373},{"date":"2023-03-10","current":-6.648873,"twenty":-30.780806,"median":-11.259169,"eighty":-7.855127,"marketCap":3152802574},{"date":"2023-03-17","current":-7.395062,"twenty":-30.780806,"median":-11.131334,"eighty":-7.837907,"marketCap":3506634689},{"date":"2023-03-24","current":-7.109208,"twenty":-30.780806,"median":-10.99242,"eighty":-7.795746,"marketCap":3371087063},{"date":"2023-03-31","current":-6.918021,"twenty":-30.767148,"median":-10.928775,"eighty":-7.754037,"marketCap":3280428586},{"date":"2023-04-06","current":-6.643305,"twenty":-30.767148,"median":-10.824667,"eighty":-7.717935,"marketCap":3150162036},{"date":"2023-04-14","current":-7.25956,"twenty":-30.780806,"median":-10.75563,"eighty":-7.702486,"marketCap":3442381594},{"date":"2023-04-21","current":-6.646815,"twenty":-30.780806,"median":-10.727603,"eighty":-7.666625,"marketCap":3151826537},{"date":"2023-04-28","current":-6.745327,"twenty":-30.780806,"median":-10.687143,"eighty":-7.629754,"marketCap":3198539850},{"date":"2023-05-05","current":-8.937919,"twenty":-30.780806,"median":-10.63589,"eighty":-7.595179,"marketCap":3847237929},{"date":"2023-05-12","current":-9.136815,"twenty":-30.780806,"median":-10.597925,"eighty":-7.595179,"marketCap":3932850438},{"date":"2023-05-18","current":-8.968904,"twenty":-30.780806,"median":-10.545224,"eighty":-7.595179,"marketCap":3860574836},{"date":"2023-05-26","current":-8.031059,"twenty":-30.794465,"median":-10.496518,"eighty":-7.592821,"marketCap":3456889157},{"date":"2023-06-02","current":-7.814004,"twenty":-30.794465,"median":-10.454135,"eighty":-7.592821,"marketCap":3363459720},{"date":"2023-06-09","current":-8.878805,"twenty":-30.808123,"median":-10.376198,"eighty":-7.590463,"marketCap":3821792806},{"date":"2023-06-16","current":-9.331346,"twenty":-30.821781,"median":-10.343314,"eighty":-7.588105,"marketCap":4016584367},{"date":"2023-06-23","current":-8.596223,"twenty":-30.834134,"median":-10.309392,"eighty":-7.587674,"marketCap":3700158256},{"date":"2023-06-30","current":-8.375072,"twenty":-30.846488,"median":-10.25804,"eighty":-7.587242,"marketCap":3604966000},{"date":"2023-07-07","current":-8.010582,"twenty":-30.846488,"median":-10.180474,"eighty":-7.587242,"marketCap":3448075059},{"date":"2023-07-14","current":-9.374347,"twenty":-30.846488,"median":-10.098818,"eighty":-7.587242,"marketCap":4035093972},{"date":"2023-07-21","current":-8.862423,"twenty":-30.846488,"median":-10.038831,"eighty":-7.587242,"marketCap":3814741527},{"date":"2023-07-28","current":-8.389406,"twenty":-30.846488,"median":-10.003118,"eighty":-7.587242,"marketCap":3611135868},{"date":"2023-08-04","current":-7.628547,"twenty":-30.846488,"median":-9.900956,"eighty":-7.587242,"marketCap":3459111235},{"date":"2023-08-11","current":-7.718318,"twenty":-30.846488,"median":-9.836152,"eighty":-7.587242,"marketCap":3499817072},{"date":"2023-08-18","current":-7.265562,"twenty":-30.846488,"median":-9.786111,"eighty":-7.577939,"marketCap":3294518068},{"date":"2023-08-25","current":-7.322156,"twenty":-30.846488,"median":-9.730929,"eighty":-7.556571,"marketCap":3320180444},{"date":"2023-09-01","current":-7.31435,"twenty":-30.846488,"median":-9.689582,"eighty":-7.523892,"marketCap":3316640806},{"date":"2023-09-08","current":-7.355332,"twenty":-30.846488,"median":-9.660875,"eighty":-7.513456,"marketCap":3335223905},{"date":"2023-09-15","current":-7.027474,"twenty":-30.871195,"median":-9.607393,"eighty":-7.488251,"marketCap":3186559109},{"date":"2023-09-22","current":-6.543494,"twenty":-30.871195,"median":-9.547953,"eighty":-7.472854,"marketCap":2967101553},{"date":"2023-09-29","current":-6.198072,"twenty":-30.871195,"median":-9.505752,"eighty":-7.463258,"marketCap":2810472572},{"date":"2023-10-06","current":-5.954131,"twenty":-30.871195,"median":-9.459456,"eighty":-7.449694,"marketCap":2699858884},{"date":"2023-10-13","current":-5.641885,"twenty":-30.871195,"median":-9.427209,"eighty":-7.429474,"marketCap":2558273364},{"date":"2023-10-20","current":-5.288658,"twenty":-30.871195,"median":-9.387069,"eighty":-7.397684,"marketCap":2398104745},{"date":"2023-10-27","current":-4.878835,"twenty":-30.938188,"median":-9.374347,"eighty":-7.39481,"marketCap":2212273750},{"date":"2023-11-03","current":-5.167662,"twenty":-30.965508,"median":-9.372489,"eighty":-7.38194,"marketCap":2343240356},{"date":"2023-11-10","current":-4.776282,"twenty":-30.965508,"median":-9.372489,"eighty":-7.36296,"marketCap":2208734112},{"date":"2023-11-17","current":-5.038985,"twenty":-30.965508,"median":-9.372489,"eighty":-7.346996,"marketCap":2330218263},{"date":"2023-11-24","current":-6.009213,"twenty":-30.965508,"median":-9.372489,"eighty":-7.322236,"marketCap":2778888267},{"date":"2023-12-01","current":-5.738091,"twenty":-30.965508,"median":-9.372489,"eighty":-7.312334,"marketCap":2653511420},{"date":"2023-12-08","current":-5.76714,"twenty":-30.938188,"median":-9.372299,"eighty":-7.282952,"marketCap":2666944653},{"date":"2023-12-15","current":-6.169949,"twenty":-30.938188,"median":-9.372299,"eighty":-7.266206,"marketCap":2853218827},{"date":"2023-12-22","current":-5.848476,"twenty":-30.938188,"median":-9.372299,"eighty":-7.263161,"marketCap":2704557708},{"date":"2023-12-29","current":-6.15252,"twenty":-30.965508,"median":-9.372489,"eighty":-7.265991,"marketCap":2845158887},{"date":"2024-01-05","current":-5.716789,"twenty":-30.992828,"median":-9.372679,"eighty":-7.266955,"marketCap":2643660382},{"date":"2024-01-12","current":-5.451477,"twenty":-30.992828,"median":-9.372679,"eighty":-7.266955,"marketCap":2520970181},{"date":"2024-01-19","current":-4.887932,"twenty":-31.020148,"median":-9.373513,"eighty":-7.266635,"marketCap":2260365448},{"date":"2024-01-26","current":-4.858883,"twenty":-30.992828,"median":-9.372679,"eighty":-7.265777,"marketCap":2246932215},{"date":"2024-02-02","current":-4.891805,"twenty":-30.992828,"median":-9.372679,"eighty":-7.265777,"marketCap":2262156546},{"date":"2024-02-09","current":-5.31979,"twenty":-30.992828,"median":-9.372679,"eighty":-7.265777,"marketCap":2460072855},{"date":"2024-02-16","current":-5.513448,"twenty":-30.992828,"median":-9.372679,"eighty":-7.265777,"marketCap":2549627746},{"date":"2024-02-23","current":-5.058484,"twenty":-30.992828,"median":-9.372679,"eighty":-7.265777,"marketCap":2434101937},{"date":"2024-03-01","current":-6.415189,"twenty":-30.965508,"median":-9.372489,"eighty":-7.25352,"marketCap":3086937728},{"date":"2024-03-08","current":-5.995765,"twenty":-30.965508,"median":-9.372489,"eighty":-7.233277,"marketCap":2885114278},{"date":"2024-03-15","current":-5.496451,"twenty":-30.965508,"median":-9.372489,"eighty":-7.154814,"marketCap":2644848265},{"date":"2024-03-22","current":-5.522415,"twenty":-30.965508,"median":-9.372489,"eighty":-7.127982,"marketCap":2657342098},{"date":"2024-03-28","current":-5.396588,"twenty":-30.965508,"median":-9.372489,"eighty":-7.108327,"marketCap":2596795063},{"date":"2024-04-05","current":-4.987151,"twenty":-30.992828,"median":-9.356614,"eighty":-7.0308,"marketCap":2399776932},{"date":"2024-04-12","current":-4.99514,"twenty":-30.992828,"median":-9.325342,"eighty":-7.015215,"marketCap":2403621189},{"date":"2024-04-19","current":-4.272871,"twenty":-30.992828,"median":-9.325342,"eighty":-6.990839,"marketCap":2056071122},{"date":"2024-04-26","current":-4.01233,"twenty":-30.965508,"median":-9.325057,"eighty":-6.956175,"marketCap":1930700932},{"date":"2024-05-03","current":-4.663682,"twenty":-30.965508,"median":-9.325057,"eighty":-6.925258,"marketCap":2244126408},{"date":"2024-05-10","current":-4.938113,"twenty":-30.965508,"median":-9.325057,"eighty":-6.917084,"marketCap":2397463794},{"date":"2024-05-17","current":-5.200312,"twenty":-30.965508,"median":-9.325057,"eighty":-6.889064,"marketCap":2524761767},{"date":"2024-05-24","current":-4.943972,"twenty":-30.965508,"median":-9.325057,"eighty":-6.805129,"marketCap":2400308474},{"date":"2024-05-31","current":-4.391551,"twenty":-30.965508,"median":-9.325057,"eighty":-6.78218,"marketCap":2132106804},{"date":"2024-06-07","current":-4.560457,"twenty":-30.965508,"median":-9.325057,"eighty":-6.745262,"marketCap":2214110911},{"date":"2024-06-14","current":-5.158582,"twenty":-30.992828,"median":-9.325342,"eighty":-6.729125,"marketCap":2504501929},{"date":"2024-06-21","current":-4.798912,"twenty":-31.020148,"median":-9.328344,"eighty":-6.698295,"marketCap":2329881417},{"date":"2024-06-28","current":-4.608148,"twenty":-31.045177,"median":-9.341584,"eighty":-6.683349,"marketCap":2237265012},{"date":"2024-07-05","current":-4.560457,"twenty":-31.045177,"median":-9.341584,"eighty":-6.647638,"marketCap":2214110911},{"date":"2024-07-12","current":-4.894294,"twenty":-31.045177,"median":-9.341584,"eighty":-6.626613,"marketCap":2376189619},{"date":"2024-07-15","current":-5.124801,"twenty":-31.045177,"median":-9.341584,"eighty":-6.584434,"marketCap":2488101107},{"date":"2024-08-02","current":-4.995638,"twenty":-31.199488,"median":-9.325057,"eighty":-6.542633,"marketCap":2425392083},{"date":"2024-08-09","current":-4.243587,"twenty":-31.199488,"median":-9.281795,"eighty":-6.525219,"marketCap":2159119921},{"date":"2024-08-16","current":-4.565909,"twenty":-31.199488,"median":-9.255,"eighty":-6.473837,"marketCap":2323116029},{"date":"2024-08-23","current":-4.591863,"twenty":-31.199488,"median":-9.23848,"eighty":-6.443558,"marketCap":2336321324},{"date":"2024-08-30","current":-4.591863,"twenty":-31.199488,"median":-9.23848,"eighty":-6.414327,"marketCap":2336321324},{"date":"2024-09-06","current":-4.178595,"twenty":-31.199488,"median":-9.23848,"eighty":-6.392758,"marketCap":2126052404},{"date":"2024-09-13","current":-4.126687,"twenty":-31.199488,"median":-9.23848,"eighty":-6.307749,"marketCap":2099641815},{"date":"2024-09-20","current":-4.577887,"twenty":-31.199488,"median":-9.23848,"eighty":-6.207937,"marketCap":2329210780},{"date":"2024-09-27","current":-4.106722,"twenty":-31.199488,"median":-9.23848,"eighty":-6.197556,"marketCap":2089483897},{"date":"2024-10-04","current":-3.523755,"twenty":-31.199488,"median":-9.23848,"eighty":-6.152215,"marketCap":1792872668},{"date":"2024-10-11","current":-3.551706,"twenty":-31.199488,"median":-9.23848,"eighty":-6.124635,"marketCap":1807093754},{"date":"2024-10-18","current":-4.188577,"twenty":-31.199488,"median":-9.23848,"eighty":-6.084285,"marketCap":2131131364},{"date":"2024-10-25","current":-3.164392,"twenty":-31.199488,"median":-9.23848,"eighty":-6.064937,"marketCap":1610030129},{"date":"2024-10-31","current":-2.86093,"twenty":-31.199488,"median":-9.23848,"eighty":-6.032734,"marketCap":1455629764},{"date":"2024-11-08","current":-3.111845,"twenty":-31.200993,"median":-9.238779,"eighty":-5.984307,"marketCap":1625267008},{"date":"2024-11-15","current":-2.948492,"twenty":-31.200993,"median":-9.238779,"eighty":-5.958474,"marketCap":1539950408},{"date":"2024-11-22","current":-2.691084,"twenty":-31.200993,"median":-9.238779,"eighty":-5.89652,"marketCap":1405510293},{"date":"2024-11-29","current":-3.045995,"twenty":-31.200993,"median":-9.238779,"eighty":-5.877007,"marketCap":1590874694},{"date":"2024-12-06","current":-2.661833,"twenty":-31.200993,"median":-9.167075,"eighty":-5.838406,"marketCap":1390233007},{"date":"2024-12-13","current":-2.644283,"twenty":-31.200993,"median":-9.162415,"eighty":-5.787281,"marketCap":1381066636},{"date":"2024-12-20","current":-2.355674,"twenty":-31.200993,"median":-9.160484,"eighty":-5.738914,"marketCap":1230330749},{"date":"2024-12-27","current":-2.363474,"twenty":-31.200993,"median":-9.160484,"eighty":-5.722397,"marketCap":1234404692},{"date":"2025-01-03","current":-2.382975,"twenty":-31.200993,"median":-9.160484,"eighty":-5.662706,"marketCap":1244589549},{"date":"2025-01-10","current":-2.343973,"twenty":-31.202498,"median":-9.16378,"eighty":-5.639393,"marketCap":1224219835},{"date":"2025-01-17","current":-1.836958,"twenty":-31.202498,"median":-9.16378,"eighty":-5.561793,"marketCap":959413548},{"date":"2025-01-24","current":-2.201619,"twenty":-31.202498,"median":-9.16378,"eighty":-5.523214,"marketCap":1149870377},{"date":"2025-01-31","current":-2.049514,"twenty":-31.202498,"median":-9.16378,"eighty":-5.495253,"marketCap":1070428491},{"date":"2025-02-07","current":-1.975412,"twenty":-31.202498,"median":-9.16378,"eighty":-5.46049,"marketCap":1031726034},{"date":"2025-02-14","current":-1.879859,"twenty":-31.202498,"median":-9.16378,"eighty":-5.439567,"marketCap":981820234},{"date":"2025-02-21","current":-2.388825,"twenty":-31.202498,"median":-9.16378,"eighty":-5.373093,"marketCap":1247645007},{"date":"2025-02-28","current":-2.13108,"twenty":-31.202498,"median":-9.16378,"eighty":-5.270155,"marketCap":1106075491},{"date":"2025-03-07","current":-1.974531,"twenty":-31.204003,"median":-9.167075,"eighty":-5.209126,"marketCap":1024822854},{"date":"2025-03-14","current":-1.838906,"twenty":-31.204003,"median":-9.167075,"eighty":-5.170588,"marketCap":954430981},{"date":"2025-03-21","current":-1.735194,"twenty":-31.204003,"median":-9.167075,"eighty":-5.145884,"marketCap":900601902},{"date":"2025-03-28","current":-1.675359,"twenty":-31.204003,"median":-9.167075,"eighty":-5.122767,"marketCap":869546664},{"date":"2025-04-04","current":-1.374194,"twenty":-31.204003,"median":-9.167075,"eighty":-5.062225,"marketCap":713235299},{"date":"2025-04-11","current":-1.35026,"twenty":-31.202498,"median":-9.16378,"eighty":-5.042858,"marketCap":700813204},{"date":"2025-04-17","current":-1.36821,"twenty":-31.202498,"median":-9.16378,"eighty":-4.996433,"marketCap":710129775},{"date":"2025-04-25","current":-1.631481,"twenty":-31.204003,"median":-9.167075,"eighty":-4.985239,"marketCap":846772822},{"date":"2025-05-02","current":-1.723227,"twenty":-31.204003,"median":-9.167075,"eighty":-4.944771,"marketCap":894390854},{"date":"2025-05-09","current":-1.629781,"twenty":-31.204003,"median":-9.167075,"eighty":-4.894958,"marketCap":857124568},{"date":"2025-05-16","current":-1.590442,"twenty":-31.204003,"median":-9.167075,"eighty":-4.864177,"marketCap":836435906},{"date":"2025-05-23","current":-1.86323,"twenty":-31.204003,"median":-9.138053,"eighty":-4.801223,"marketCap":979898907},{"date":"2025-05-30","current":-1.467343,"twenty":-31.204003,"median":-9.138053,"eighty":-4.7649,"marketCap":771696285},{"date":"2025-06-06","current":-1.492948,"twenty":-31.204003,"median":-9.036477,"eighty":-4.714446,"marketCap":785162126},{"date":"2025-06-13","current":-1.644606,"twenty":-31.204003,"median":-8.98938,"eighty":-4.66554,"marketCap":864921339},{"date":"2025-06-20","current":-1.890805,"twenty":-31.205508,"median":-8.932045,"eighty":-4.612937,"marketCap":994400582},{"date":"2025-06-27","current":-1.892774,"twenty":-31.205508,"median":-8.895293,"eighty":-4.591863,"marketCap":995436416},{"date":"2025-07-03","current":-2.115338,"twenty":-31.205508,"median":-8.875733,"eighty":-4.577887,"marketCap":1112485651}],"updateTime":1751673315941}}}